Sciformix
Leading the Pack with Trusted Services Built on Science to the Pharma & Life Science Industry
Fran Bates, Vice President, Technology ServicesSciformix offers end-to-end integrated services spanning the complete spectrum of the product lifecycle
An example of the company’s comprehensive offerings can be demonstrated in how they support all aspects of Safety and Risk Management including clinical trial and post-launch activities: from Medical Call Center, Pharmacovigilance (PV) & Case Management, to Aggregate Reporting, Signal Detection & Risk Management, and Safety Consulting. Probing deeper, Sciformix’s overarching automated enterprise technology platform, SciPortal, underpins these activities and enables businesses to track their entire lifecycle process, monitor metrics, and extract meaningful reports via mobile devices.
According to Fran, amongst the critical challenges organizations face is the lack of IT expertise required to efficiently access scientific and medical knowledge across all aspects of the product lifecycle. “Organizations typically prioritize, and therefore staff, drug discovery efforts over building end-to-end scientific and technological processes required for product success,” he adds. Sciformix’s capabilities help address this crital industry bottleneck. The company supports its clients by helping them build “Pharmacovigilance IT” architecture, deploy signal detection applications, and create enterprise portals for safety reporting and analytics. Alongside employing these solutions, clients are able to adhere to and effectively maintain regulatory compliance and technology validation requirements. By facilitating continuous improvement across the entire drug development lifecycle, Sciformix helps organizations to innovate, simplify, and constantly revamp their operations.
One of Sciformix’s clients, a global pharmaceutical company that offers prescription drugs and is actively engaged in R&D, had been struggling to deal with its multiple subsidiaries, each having safety data in disparate systems. Consequently, it was difficult for the organization to access the data, make informed decisions, and manage reporting to regulatory authorities. The company needed to centralize and streamline its safety data. Given this scenario, Sciformix employed its Sciformix Accelerator Methodology to ensure that every aspect of the project was planned and executed timely and efficiently. By implementing this flexible and state-of-art IT QMS and virtualization methodology, Sciformix was able to deliver a validated Sciformix Cloud safety database solution in less than 38 days.
“Innovation is a core value at Sciformix,” stresses Fran. Moreover, the zeal of innovating enables Sciformix to recognize and exploit opportunities for technological transformations that facilitate their abilities to implement extraordinary practices. Fuelled by an unrivaled commitment to quality, Sciformix aims to continue providing its clients outstanding services and solutions, and being agile, flexible, and scalable while expanding its global footprint via organic and inorganic avenues.
According to Fran, amongst the critical challenges organizations face is the lack of IT expertise required to efficiently access scientific and medical knowledge across all aspects of the product lifecycle. “Organizations typically prioritize, and therefore staff, drug discovery efforts over building end-to-end scientific and technological processes required for product success,” he adds. Sciformix’s capabilities help address this crital industry bottleneck. The company supports its clients by helping them build “Pharmacovigilance IT” architecture, deploy signal detection applications, and create enterprise portals for safety reporting and analytics. Alongside employing these solutions, clients are able to adhere to and effectively maintain regulatory compliance and technology validation requirements. By facilitating continuous improvement across the entire drug development lifecycle, Sciformix helps organizations to innovate, simplify, and constantly revamp their operations.
One of Sciformix’s clients, a global pharmaceutical company that offers prescription drugs and is actively engaged in R&D, had been struggling to deal with its multiple subsidiaries, each having safety data in disparate systems. Consequently, it was difficult for the organization to access the data, make informed decisions, and manage reporting to regulatory authorities. The company needed to centralize and streamline its safety data. Given this scenario, Sciformix employed its Sciformix Accelerator Methodology to ensure that every aspect of the project was planned and executed timely and efficiently. By implementing this flexible and state-of-art IT QMS and virtualization methodology, Sciformix was able to deliver a validated Sciformix Cloud safety database solution in less than 38 days.
“Innovation is a core value at Sciformix,” stresses Fran. Moreover, the zeal of innovating enables Sciformix to recognize and exploit opportunities for technological transformations that facilitate their abilities to implement extraordinary practices. Fuelled by an unrivaled commitment to quality, Sciformix aims to continue providing its clients outstanding services and solutions, and being agile, flexible, and scalable while expanding its global footprint via organic and inorganic avenues.
